Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982442priorityCriticalpatent/ECSP982442A/en
Publication of ECSP982442ApublicationCriticalpatent/ECSP982442A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
El invento se refiere a inhibidores obtenibles por sintesis quimica, que inhiben o bloquean la actividad biológica y la enzima de la proteasa del VIH, haciendo que termine la replicación del virus del VIH. Estos compuestos, asi como las composiciones farmacéuticas que los contienen y opcionalmente otros agentes antiviricos como ingredientes activos, son aptos para tratar a pacientes huéspedes infectados con el virus del VIH, que se conoce como causa del SIDA.The invention relates to inhibitors obtainable by chemical synthesis, which inhibit or block the biological activity and enzyme of the HIV protease, causing the replication of the HIV virus to stop. These compounds, as well as the pharmaceutical compositions containing them and optionally other antiviral agents as active ingredients, are suitable for treating host patients infected with the HIV virus, which is known as the cause of AIDS.
ECSP9824421998-03-111998-03-11
HIV PROTEASE INHIBITORS
ECSP982442A
(en)